Hossein Motedayyen

514 total citations
25 papers, 370 citations indexed

About

Hossein Motedayyen is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Hossein Motedayyen has authored 25 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Hossein Motedayyen's work include T-cell and B-cell Immunology (4 papers), Mesenchymal stem cell research (3 papers) and Immune Cell Function and Interaction (3 papers). Hossein Motedayyen is often cited by papers focused on T-cell and B-cell Immunology (4 papers), Mesenchymal stem cell research (3 papers) and Immune Cell Function and Interaction (3 papers). Hossein Motedayyen collaborates with scholars based in Iran, United States and India. Hossein Motedayyen's co-authors include Nahid Eskandari, Somayeh Ghotloo, Farshid Fathi, Reza Amid, Mahmood Saffari, Mandana Sattari, Reza Arefnezhad, Ramin Sami, Samaneh Mozafarpoor and Nafiseh Esmaeil and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Periodontology and Archives of Microbiology.

In The Last Decade

Hossein Motedayyen

23 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hossein Motedayyen Iran 11 110 84 76 53 51 25 370
Hitendra S. Solanki United States 13 266 2.4× 61 0.7× 103 1.4× 80 1.5× 22 0.4× 26 478
Fatemeh Ezzatifar Iran 12 228 2.1× 92 1.1× 78 1.0× 67 1.3× 11 0.2× 23 439
Yousef Salama Japan 12 155 1.4× 74 0.9× 116 1.5× 85 1.6× 9 0.2× 31 449
Amarnath S. Marudamuthu United States 12 194 1.8× 67 0.8× 122 1.6× 53 1.0× 11 0.2× 19 620
Naoko Ishida Japan 14 148 1.3× 122 1.5× 75 1.0× 161 3.0× 38 0.7× 39 515
Daiana Giannini Italy 4 160 1.5× 108 1.3× 62 0.8× 80 1.5× 11 0.2× 7 500
Llewellyn Spargo Australia 11 72 0.7× 97 1.2× 15 0.2× 41 0.8× 21 0.4× 22 406
Xiaolin Sun China 11 161 1.5× 26 0.3× 49 0.6× 33 0.6× 24 0.5× 49 458
Emily J. Anstadt United States 11 289 2.6× 122 1.5× 16 0.2× 199 3.8× 50 1.0× 28 559
Gökhan Demir Türkiye 12 100 0.9× 30 0.4× 59 0.8× 85 1.6× 10 0.2× 31 408

Countries citing papers authored by Hossein Motedayyen

Since Specialization
Citations

This map shows the geographic impact of Hossein Motedayyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hossein Motedayyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hossein Motedayyen more than expected).

Fields of papers citing papers by Hossein Motedayyen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hossein Motedayyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hossein Motedayyen. The network helps show where Hossein Motedayyen may publish in the future.

Co-authorship network of co-authors of Hossein Motedayyen

This figure shows the co-authorship network connecting the top 25 collaborators of Hossein Motedayyen. A scholar is included among the top collaborators of Hossein Motedayyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hossein Motedayyen. Hossein Motedayyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chahardehi, Amir Modarresi, et al.. (2025). Unveiling the potential benefits of statins in medulloblastoma treatment: A promising therapeutic approach. IBRO Neuroscience Reports. 19. 532–542.
2.
Zamani, Batool, et al.. (2025). Impacts of adipokines in the development and consequence of COVID-19-associated mucormycosis. Archives of Microbiology. 207(11). 303–303.
3.
Arefnezhad, Reza, et al.. (2024). Quercetin and its nanoformulations as promising agents for lung cancer treatment: A focus on molecular mechanisms. Journal of Drug Delivery Science and Technology. 99. 105933–105933. 3 indexed citations
4.
Fattahi, Mohammad Reza, et al.. (2024). Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers. Frontiers in Oncology. 14. 1438297–1438297. 6 indexed citations
5.
Arefnezhad, Reza, et al.. (2023). Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer?. Cell Biology International. 47(4). 714–719. 6 indexed citations
6.
Mohammadi, Mohsen, et al.. (2022). Impact of oligomerization on the allergenicity of allergens. Clinical and Molecular Allergy. 20(1). 5–5. 11 indexed citations
7.
8.
Fathi, Farshid, Rezà F. Saidi, Hamid Reza Banafshe, et al.. (2022). Changes in immune profile affect disease progression in hepatocellular carcinoma. International Journal of Immunopathology and Pharmacology. 36. 1190298572–1190298572. 7 indexed citations
9.
Fathi, Farshid, Batool Zamani, Ahmad Piroozmand, et al.. (2021). Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma. Molecular Biology Reports. 48(3). 2047–2052. 11 indexed citations
10.
Karimifar, Mansoor, et al.. (2021). Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index. BMC Research Notes. 14(1). 455–455. 5 indexed citations
11.
12.
Fathi, Farshid, Ramin Sami, Samaneh Mozafarpoor, et al.. (2020). Immune system changes during COVID-19 recovery play key role in determining disease severity. International Journal of Immunopathology and Pharmacology. 34. 1682203745–1682203745. 33 indexed citations
13.
Fathi, Farshid, et al.. (2019). Association of programmed death‐1 gene polymorphisms with the risk of basal cell carcinoma. International Journal of Immunogenetics. 46(6). 444–450. 15 indexed citations
14.
Eskandari, Nahid, et al.. (2019). Therapeutic potential of quercetin on human breast cancer in different dimensions. Inflammopharmacology. 28(1). 39–62. 57 indexed citations
15.
Motedayyen, Hossein, et al.. (2019). The Effects of Silymarin and Cyclosporine A on the Proliferation and Cytokine Production of Regulatory T Cells. Immunological Investigations. 48(5). 533–548. 9 indexed citations
16.
Fathi, Farshid, et al.. (2019). Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus. International Journal of Immunogenetics. 47(1). 57–64. 15 indexed citations
17.
Fathi, Farshid, et al.. (2019). Regulatory T-cells and their impacts on cytokine profile of end-stage renal disease patients suffering from systemic lupus erythematosus. International Journal of Immunopathology and Pharmacology. 33. 1681100486–1681100486. 14 indexed citations
18.
Motedayyen, Hossein, et al.. (2018). Comparison of the Percentage of Regulatory T cells and their p-STAT5 Expression in Allergic and Non-Allergic Common Variable Immunodeficiency Patients. Immunological Investigations. 48(1). 52–63. 10 indexed citations
19.
Motedayyen, Hossein, Nafiseh Esmaeil, Nader Tajik, et al.. (2017). Method and key points for isolation of human amniotic epithelial cells with high yield, viability and purity. BMC Research Notes. 10(1). 552–552. 36 indexed citations
20.
Motedayyen, Hossein, Somayeh Ghotloo, Mahmood Saffari, Mandana Sattari, & Reza Amid. (2015). Evaluation of MicroRNA‐146a and Its Targets in Gingival Tissues of Patients With Chronic Periodontitis. Journal of Periodontology. 86(12). 1380–1385. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitendra S. Solanki Breakdown of academic impact, for papers by Fatemeh Ezzatifar Breakdown of academic impact, for papers by Yousef Salama Breakdown of academic impact, for papers by Amarnath S. Marudamuthu Breakdown of academic impact, for papers by Naoko Ishida Breakdown of academic impact, for papers by Daiana Giannini Breakdown of academic impact, for papers by Llewellyn Spargo Breakdown of academic impact, for papers by Xiaolin Sun Breakdown of academic impact, for papers by Emily J. Anstadt Breakdown of academic impact, for papers by Gökhan Demir
Rankless by CCL
2026